Eukaryotic translation initiation factors as promising targets in cancer therapy
P Hao, J Yu, R Ward, Y Liu, Q Hao, S An… - Cell Communication and …, 2020 - Springer
The regulation of the translation of messenger RNA (mRNA) in eukaryotic cells is critical for
gene expression, and occurs principally at the initiation phase which is mainly regulated by …
gene expression, and occurs principally at the initiation phase which is mainly regulated by …
ERK is a pivotal player of chemo-immune-resistance in cancer
IC Salaroglio, E Mungo, E Gazzano, J Kopecka… - International journal of …, 2019 - mdpi.com
The extracellular signal-related kinases (ERKs) act as pleiotropic molecules in tumors,
where they activate pro-survival pathways leading to cell proliferation and migration, as well …
where they activate pro-survival pathways leading to cell proliferation and migration, as well …
Phosphorylation of the mRNA cap-binding protein eIF4E and cancer
X Yang, W Zhong, R Cao - Cellular signalling, 2020 - Elsevier
Dysregulated protein synthesis is frequently involved in oncogenesis and cancer
progression. Translation initiation is thought to be the rate-limiting step in protein synthesis …
progression. Translation initiation is thought to be the rate-limiting step in protein synthesis …
Enhanced chemotherapeutic efficacy of paclitaxel nanoparticles co-delivered with microRNA-7 by inhibiting paclitaxel-induced EGFR/ERK pathway activation for …
X Cui, Y Sun, M Shen, K Song, X Yin… - ACS applied materials …, 2018 - ACS Publications
Chemotherapy-induced activation of cell survival pathways leads to drug resistance.
MicroRNAs (miRNAs) post-transcriptionally regulate gene expression in many biological …
MicroRNAs (miRNAs) post-transcriptionally regulate gene expression in many biological …
Dee** in the role of the MAP-kinases interacting kinases (MNKs) in cancer
C Pinto-Díez, R Ferreras-Martín… - International Journal of …, 2020 - mdpi.com
The mitogen-activated protein kinase (MAPK)-interacting kinases (MNKs) are involved in
oncogenic transformation and can promote metastasis and tumor progression. In human …
oncogenic transformation and can promote metastasis and tumor progression. In human …
The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib
A Sánchez‐Fdez, S Matilla‐Almazán… - Clinical and …, 2023 - Wiley Online Library
Background The dismal prognosis of advanced ovarian cancer calls for the development of
novel therapies to improve disease outcome. In this regard, we set out to discover new …
novel therapies to improve disease outcome. In this regard, we set out to discover new …
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ
The mechanisms by which breast cancers progress from relatively indolent ductal carcinoma
in situ (DCIS) to invasive ductal carcinoma (IDC) are not well understood. However, this …
in situ (DCIS) to invasive ductal carcinoma (IDC) are not well understood. However, this …
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
L Zhao, Y Zhang, A Li, X Lu, M Li, Q Yuan… - Molecular Therapy …, 2022 - cell.com
Epidemiological and mechanistic studies suggest that some US Food and Drug
Administration (FDA)-approved drugs can reduce the incidence of cancer and inhibit tumor …
Administration (FDA)-approved drugs can reduce the incidence of cancer and inhibit tumor …
[HTML][HTML] Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy
Ovarian carcinoma is one of the most common causes for cancer death in women; lack of
early diagnosis and acquired resistance to platinum-based chemotherapy account for its …
early diagnosis and acquired resistance to platinum-based chemotherapy account for its …
Computational investigations on reaction mechanisms of the covalent inhibitors ponatinib and analogs targeting the extracellular signal-regulated kinases
Y Tian, M Zhang, P Heng, H Hou, B Wang - International Journal of …, 2023 - mdpi.com
As an important cancer therapeutic target, extracellular signal-regulated kinases (ERK) are
involved in triggering various cellular responses in tumors. Regulation of the ERK signaling …
involved in triggering various cellular responses in tumors. Regulation of the ERK signaling …